Together, we can cure single ventricle.
Additional Ventures’ mission is to cure single ventricle heart disease through transformative research and strategic investments that revolutionize treatment and care.
We spur catalytic collaboration within the single ventricle community, facilitate faster and better science through agile approaches to research funding, and ensure researchers have the resources needed to drive toward a cure — all with intentionality, optimism, and urgency.
For Patients and Families
Explore our approach to improving quality of life for single ventricle patients through research
Since 2020, Additional Ventures has been embedded within the biomedical research community, optimizing and accelerating high-quality single ventricle research.
We are inspired by progress made to date…
$95M+
in single ventricle research funding
200+
studies aimed at understanding and curing single ventricle
125+
research publications from Additional Ventures funded researchers
